AIM Vaccine Co (HKSE:06660) Tariff Resilience Score: 0/10 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06660 AIM Vaccine Co Ltd HKSE:06660
61 GF Score
Price HK$1.59
GF Value HK$4.08
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is AIM Vaccine Co Tariff Resilience Score?

AIM Vaccine Co has the Tariff Resilience Score of 0, which implies that the company might have .

AIM Vaccine Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes AIM Vaccine Co might have .

AIM Vaccine Co  (HKSE:06660) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

AIM Vaccine Co Tariff Resilience Score Related Terms

HKSE:06660
61GF Score
AIM Vaccine Co Ltd HKSE:06660
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AIM Vaccine Co (HKSE:06660) Overvalued in 2026?

Based on GuruFocus' analysis, AIM Vaccine Co stock appears to be undervalued. The current stock price of HK$1.59 is trading 61% below its estimated GF Value™ of HK$4.08. GuruFocus considers AIM Vaccine Co to be Possible Value Trap.

Key valuation signals for HKSE:06660:

  • Tariff Resilience Score: 0
  • GF Value™: HK$4.08 vs. price of HK$1.59 (61% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the HKSE:06660 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AIM Vaccine Co Business Description

Address 2 Ronghua South Road, 26th Floor, Building T6, Han’s Plaza, Economic Technological Development Area, Beijing, CHN
AIM Vaccine Co Ltd is a China-based full-chain vaccine company engaged in the research and development, manufacturing, and commercialization of vaccine products. The company's commercialized products include recombinant HBV vaccines, freeze-dried human rabies vaccines, inactivated HAV vaccines, Group A, C, Y, and W135 meningococcal polysaccharide vaccines, bivalent inactivated HFRS vaccines, and mumps vaccines. The company generates the majority of its revenue from the PRC.
61GF Score

Get the complete analysis for HKSE:06660

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.59
Price
HK$4.08
GF Value